Clinipace is a clinical research organization that provides fully integrated clinical research services for biopharmaceutical and medical device firms. With a personal approach to clinical research, the company offers extensive regulatory expertise and core therapeutic specialties in oncology, nephrology, rare disease, gastroenterology, and women's health. Founded in 2003 and headquartered in Morrisville, North Carolina, Clinipace delivers a level of collaboration and flexibility not possible in a traditional CRO environment. In 2021, Clinipace merged with dMed to form Caidya, a multi-therapeutic clinical research organization with nearly 1,800 employees in 30+ countries worldwide. Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy through clinical development to submission and post-marketing surveillance. The company leverages industry-leading and proprietary clinical technology to ensure trial transparency and data-driven decision-making, focused on delivery excellence and an elevated customer experience.